MANNKIND CORP Earnings Per Share (Basic)
MANNKIND CORP (MNKD) reported Earnings Per Share (Basic) of -$0.06 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- MANNKIND CORP earnings per share, basic for the quarter ending 2026-06-30 was -$0.06.
- MANNKIND CORP earnings per share, basic for the quarter ending 2026-03-31 was -$0.05, a 225.00% decline year-over-year.
- MANNKIND CORP earnings per share, basic for the quarter ending 2025-09-30 was $0.03, a 25.00% decline year-over-year.
- MANNKIND CORP earnings per share, basic for the quarter ending 2025-06-30 was $0.00.
- MANNKIND CORP earnings per share, basic for fiscal 2025 was $0.02, a 80.00% decline from fiscal 2024.
- MANNKIND CORP earnings per share, basic for fiscal 2024 was $0.10.
- MANNKIND CORP earnings per share, basic for fiscal 2023 was -$0.04.
- MANNKIND CORP earnings per share, basic for fiscal 2022 was -$0.34.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.06 10-Q · filed 2026-08-05 | -$0.12 10-Q · filed 2026-08-05 | ||||
| 2026-03-31 | -$0.05 10-Q · filed 2026-05-06 | |||||
| 2025-12-31 | $0.02 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $0.03 10-Q · filed 2025-11-05 | $0.07 10-Q · filed 2025-11-05 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 | $0.05 10-Q · filed 2026-08-05 | ||||
| 2025-03-31 | $0.04 10-Q · filed 2026-05-06 | |||||
| 2024-12-31 | $0.10 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $0.04 10-Q · filed 2025-11-05 | $0.07 10-Q · filed 2025-11-05 | ||||
| 2024-06-30 | -$0.01 10-Q · filed 2025-08-06 | $0.03 10-Q · filed 2025-08-06 | ||||
| 2024-03-31 | $0.04 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | -$0.04 10-K · filed 2026-02-26 | |||||
| 2023-09-30 | $0.01 10-Q · filed 2024-11-07 | -$0.05 10-Q · filed 2024-11-07 | ||||
| 2023-06-30 | -$0.02 10-Q · filed 2024-08-07 | -$0.06 10-Q · filed 2024-08-07 | ||||
| 2023-03-31 | -$0.04 10-Q · filed 2024-05-08 | |||||
| 2022-12-31 | -$0.34 10-K · filed 2025-02-26 | |||||
| 2022-09-30 | -$0.06 10-Q · filed 2023-11-07 | -$0.27 10-Q · filed 2023-11-07 | ||||
| 2022-06-30 | -$0.11 10-Q · filed 2023-08-07 | -$0.22 10-Q · filed 2023-08-07 | ||||
| 2022-03-31 | -$0.10 10-Q · filed 2023-05-09 | |||||
| 2021-12-31 | -$0.32 10-K · filed 2024-02-27 | |||||
| 2021-09-30 | -$0.02 10-Q · filed 2022-11-08 | -$0.21 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | -$0.14 10-Q · filed 2022-08-09 | -$0.20 10-Q · filed 2022-08-09 | ||||
| 2020-12-31 | -$0.26 10-K · filed 2023-02-23 | |||||
| 2018-12-31 | -$0.06 10-K · filed 2019-02-26 | -$0.60 10-K · filed 2019-02-26 | ||||
| 2018-09-30 | -$0.16 10-K · filed 2019-02-26 | |||||
| 2018-06-30 | -$0.16 10-K · filed 2019-02-26 | |||||
| 2018-03-31 | -$0.25 10-K · filed 2019-02-26 | |||||
| 2017-12-31 | -$0.28 10-K · filed 2019-02-26 | -$1.13 10-K · filed 2019-02-26 | ||||
| 2017-09-30 | -$0.31 10-K · filed 2019-02-26 | -$0.84 10-Q · filed 2017-11-07 | ||||
| 2017-06-30 | -$0.35 10-K · filed 2019-02-26 | |||||
| 2017-03-31 | -$0.17 10-K · filed 2019-02-26 | |||||
| 2016-12-31 | $0.56 10-K · filed 2018-02-27 | $1.37 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $1.32 10-K · filed 2018-02-27 | $0.26 10-Q · filed 2016-11-09 | $0.79 10-Q · filed 2017-11-07 | $0.16 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | -$0.33 10-K · filed 2018-02-27 | |||||
| 2016-03-31 | -$0.29 10-K · filed 2018-02-27 | |||||
| 2015-12-31 | -$4.54 10-K · filed 2018-02-27 | |||||
| 2015-09-30 | -$0.08 10-Q · filed 2016-11-09 | -$0.23 10-Q · filed 2016-11-09 | ||||
| 2014-12-31 | -$2.57 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |